Arylamino Purine Derivatives, Preparation Method and Pharmaceutical Use Thereof
申请人:Yang Shengyong
公开号:US20130203986A1
公开(公告)日:2013-08-08
Arylamino purine derivatives represented by formula I and their preparation method are disclosed, wherein each substituent is defined as in the description. The derivatives have an inhibitory effect on non-small cell lung cancer with deletion mutation of exon 19 or L858R point mutation of exon 21 in epidermal growth factor receptor (EGFR).